Jacobs & Co
- SEC CIK
- 0001055544
- Latest filing
- Jul 8, 2026
SNY holding history
Sanofi in every 13F filed by Jacobs & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SNY overviewAll 13F holders of SNYFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −4,305−100.0% | Sold out | Holders |
| Q1 2026 | 4,305 | $207.0K | <0.1% | −1,510−26.0% | Reduced | Holders |
| Q4 2025 | 5,815 | $281.0K | <0.1% | −725−11.1% | Reduced | Holders |
| Q3 2025 | 6,540 | $308.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 6,540 | $315.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 6,540 | $362.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 6,540 | $315.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 6,540 | $376.0K | <0.1% | −150−2.2% | Reduced | Holders |
| Q2 2024 | 6,690 | $324.0K | <0.1% | −225−3.3% | Reduced | Holders |
| Q1 2024 | 6,915 | $336.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 6,915 | $343.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 6,915 | $370.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 6,915 | $372.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 6,915 | $376.0K | <0.1% | −1,028−12.9% | Reduced | Holders |
| Q4 2022 | 7,943 | $384.0K | <0.1% | −1,387−14.9% | Reduced | Holders |
| Q3 2022 | 9,330 | $354.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 9,330 | $466.0K | 0.1% | −1,000−9.7% | Reduced | Holders |
| Q1 2022 | 10,330 | $530.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 10,330 | $517.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 10,330 | $498.0K | 0.1% | −1,000−8.8% | Reduced | Holders |
| Q2 2021 | 11,330 | $596.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 11,330 | $560.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.